AI Medical Compendium Journal:
Briefings in bioinformatics

Showing 11 to 20 of 849 articles

Advances and critical aspects in cancer treatment development using digital twins.

Briefings in bioinformatics
The emergence of digital twins (DTs) in the arena of anticancer treatment echoes the transformative impact of artificial intelligence in drug development. DTs provide dynamic, accessible platforms that may accurately replicate patient and tumor chara...

Integrated multimodal hierarchical fusion and meta-learning for enhanced molecular property prediction.

Briefings in bioinformatics
Accurately predicting the pharmacological and toxicological properties of molecules is a critical step in the drug development process. Owing to the heterogeneity of molecular property prediction tasks, most of the current methods rely on building a ...

LightCTL: lightweight contrastive TCR-pMHC specificity learning with context-aware prompt.

Briefings in bioinformatics
Identification of T cell receptor (TCR) specificities for antigens from large-scale single-cell or bulk TCR repertoire data plays a vital role in disease diagnosis and immunotherapy. In silico prediction models have emerged in recent years. However, ...

PLM-DBPs: enhancing plant DNA-binding protein prediction by integrating sequence-based and structure-aware protein language models.

Briefings in bioinformatics
DNA-binding proteins (DBPs) play a crucial role in gene regulation, development, and environmental responses across plants, animals, and microorganisms. Existing DBP prediction methods are largely limited to sequence information, whether through hand...

scaLR: a low-resource deep neural network-based platform for single cell analysis and biomarker discovery.

Briefings in bioinformatics
Single-cell ribonucleic acid (RNA) sequencing (scRNA-seq) produces vast amounts of individual cell profiling data. Its analysis presents a significant challenge in accurately annotating cell types and their associated biomarkers. Different pipelines ...

Large-scale information retrieval and correction of noisy pharmacogenomic datasets through residual thresholded deep matrix factorization.

Briefings in bioinformatics
Pharmacogenomics studies are attracting an increasing amount of interest from researchers in precision medicine. The advances in high-throughput experiments and multiplexed approaches allow the large-scale quantification of drug sensitivities in mole...

Machine learning-augmented m6A-Seq analysis without a reference genome.

Briefings in bioinformatics
Methylated RNA m6A immunoprecipitation sequencing (m6A-Seq) is a powerful technique for investigating transcriptome-wide m6A modification. However, most of the existing m6A-Seq protocols rely on reference genomes, limiting their use in species lackin...

GAEDGRN: reconstruction of gene regulatory networks based on gravity-inspired graph autoencoders.

Briefings in bioinformatics
Reconstructing high-resolution gene regulatory networks (GRNs) based on single-cell RNA sequencing data provides an opportunity to gain insight into disease pathogenesis. At present, there are a large number of GRN reconstruction methods based on gra...

NNKcat: deep neural network to predict catalytic constants (Kcat) by integrating protein sequence and substrate structure with enhanced data imbalance handling.

Briefings in bioinformatics
Catalytic constant (Kcat) is to describe the efficiency of catalyzing reactions. The Kcat value of an enzyme-substrate pair indicates the rate an enzyme converts saturated substrates into product during the catalytic process. However, it is challengi...

MMsurv: a multimodal multi-instance multi-cancer survival prediction model integrating pathological images, clinical information, and sequencing data.

Briefings in bioinformatics
Accurate prediction of patient survival rates in cancer treatment is essential for effective therapeutic planning. Unfortunately, current models often underutilize the extensive multimodal data available, affecting confidence in predictions. This stu...